Nuvalent NUVL
NUVL
$123.96 +0.00 (+0.00%)
At close: Jul 21, 2026 · 4:00 PM EDT

Nuvalent (NUVL) Interest & Investment Income (2021 - 2026)

Nuvalent's (NUVL) quarterly Interest & Investment Income came in at $12.9 million in Q1 2026, up 8.68% YoY from $11.8 million in Q1 2025, and up 10.94% on a QoQ basis from $11.6 million in Q4 2025.

Analysis

Nuvalent (NUVL) Interest & Investment Income (2021 - 2026) Analysis & Trends

Nuvalent (NUVL) has 5 years of Interest & Investment Income data on file, last reported at $12.9 million in Q1 2026.

  • Quarterly Interest & Investment Income rose 8.68% year-over-year to $12.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $45.8 million (up 9.67% YoY) and the FY2025 annual result came in at $44.8 million, up 16.65% from the prior year.
  • Interest & Investment Income grew to $12.9 million in Q1 2026, from $11.6 million in the prior quarter.
  • In the past five years, Interest & Investment Income ranged from a high of $13.1 million in Q4 2024 to a low of $139000.0 in Q1 2022.
  • A 5-year average of $7.3 million and a median of $8.2 million in 2023 frame the typical range for Interest & Investment Income.
  • Annual changes were most pronounced in 2023 — Interest & Investment Income soared 3510.07% — and 2025, when it decreased 11.5%.
  • Tracing NUVL's Interest & Investment Income over 5 years: stood at $3.2 million in 2022, then surged by 156.82% to $8.2 million in 2023, then surged by 60.3% to $13.1 million in 2024, then slipped by 11.5% to $11.6 million in 2025, then climbed by 10.94% to $12.9 million in 2026.
  • The last three Interest & Investment Income figures came in at $12.9 million (Q1 2026), $11.6 million (Q4 2025), and $10.2 million (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 120.60 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -48.00 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 48.00 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 67.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 35.58 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 27.90 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 28.14 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 5.13 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 10.98 Mn
10 Nuvalent 9.75 Bn 9.75 Bn - 12.90 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 12.90 Mn
Dec 31, 2025 11.60 Mn
Sep 30, 2025 10.20 Mn
Jun 30, 2025 11.12 Mn
Mar 31, 2025 11.84 Mn
Dec 31, 2024 13.10 Mn
Sep 30, 2024 8.70 Mn
Jun 30, 2024 8.15 Mn
Mar 31, 2024 8.50 Mn
Dec 31, 2023 8.17 Mn
Sep 30, 2023 5.14 Mn
Jun 30, 2023 4.97 Mn
Mar 31, 2023 5.02 Mn
Dec 31, 2022 3.22 Mn
Sep 30, 2022 672,000.00
Jun 30, 2022 267,000.00
Mar 31, 2022 139,000.00
Dec 31, 2021 114,000.00